Peptide Report
DSIP Peptide Report
Catalog report for DSIP, generated from Peptide Stacks product data and linked to the matching PeptideReports protocol page when available.
Current Price$54.99 – $124.99 CAD
Common Uses
People commonly use DSIP in sleep-focused routines, especially when they are looking for support around sleep quality, restfulness, and recovery from poor sleep patterns.
How It Works
DSIP is a small peptide originally associated with sleep regulation. Its mechanism is not as cleanly defined as many receptor-targeted peptides, but it is discussed in relation to stress-axis modulation, neuroendocrine signaling, and sleep-state regulation.
Storage
Powder form: In lyophilized powder form, DSIP is generally kept sealed, dry, protected from direct light, and refrigerated unless the product label or certificate of analysis gives different handling instructions. Avoid leaving vials in hot rooms, vehicles, direct sunlight, or other temperature swings, because moisture, heat, and light are the main storage conditions people try to control before reconstitution.
Reconstituted: After reconstitution, DSIP should generally be treated as more sensitive: keep it refrigerated, minimize unnecessary handling, avoid shaking, and use clean handling practices each time the vial is accessed. Follow the product label, protocol page, and any pharmacy or lab guidance for beyond-use timing; if the solution changes color, becomes cloudy, develops particles, or the vial integrity is questionable, it should not be used.
Protocol
The full DSIP protocol is included below. The standalone protocol page remains available if you want to open it separately.
Open Standalone Protocol
Scope
Preparation examples, syringe conversion, community-reported patterns and important limitations.
Available strengths: 10 MG and 15 MG
Preparation Examples
These are calculation examples only. The concentration assumptions below are explicit so syringe units are never separated from vial strength and diluent volume.
| Setup |
Diluent |
Concentration |
Unit conversion |
| 10 MG vial – 2 mL example |
Add 2 mL bacteriostatic water |
5 mg/mL |
Each U-100 unit = 50 mcg |
| 15 MG vial – 3 mL example |
Add 3 mL bacteriostatic water |
5 mg/mL |
Each U-100 unit = 50 mcg |
Syringe Conversion
| Reported amount |
10 MG setup |
15 MG setup |
| 100 mcg |
2 units |
2 units |
| 200 mcg |
4 units |
4 units |
| 300 mcg |
6 units |
6 units |
| 500 mcg |
10 units |
10 units |
Always recalculate from the actual vial strength and diluent volume. A U-100 unit is 0.01 mL; it is not a dose by itself.
Community-Reported Patterns
| Recurring report |
Frequency seen |
Context in reports |
| 100 mcg |
Before bedtime |
Lower-start reports |
| 200-300 mcg |
Before bedtime |
Most recurring range |
| 500 mcg |
Before bedtime in some reports |
Higher experimental use |
Observations
- Community discussions most often centered on sleep onset, sleep quality and stress-related goals.
- The amount, frequency, route and cycle length varied substantially between reports.
- Reported outcomes were commonly confounded by diet, training, other products or existing treatment.
Caveats
- DSIP evidence is limited and inconsistent; sedation, paradoxical wakefulness and interaction with other substances are unresolved.
- Community reports are uncontrolled anecdotes and do not establish an appropriate dose, safety, product identity, purity or efficacy.